(FM) Inmunología
Departamento académico
University of Alabama at Birmingham
Birmingham, Estados UnidosPublications in collaboration with researchers from University of Alabama at Birmingham (1)
2024
-
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
Annals of Oncology, Vol. 35, Núm. 6, pp. 537-548